Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

3.96
Delayed Data
As of 4:03pm ET
 -0.14 / -3.41%
Today’s Change
1.27
Today|||52-Week Range
7.10
+179.07%
Year-to-Date
Institutional investors purchased a net $8.3 million shares of RNN during the quarter ended March 2017 and now own 6.02% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Individual stakeholders8.04%
Mutual fund holders3.82%
Other institutional2.20%

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

3/31/2017THE VANGUARD GROUP, INC.  Bought 2.9 Million shares of Rexahn Pharmaceuticals In...
3/31/2017RENAISSANCE TECHNOLOGIES LLC  Bought 862.0 Thousand shares of Rexahn Pharmaceuticals In...
3/31/2017GEODE CAPITAL MANAGEMENT LLC  Bought 374.0 Thousand shares of Rexahn Pharmaceuticals In...

Top 10 Owners of Rexahn Pharmaceuticals Inc

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Renaissance Technologies LLC2.42%5,758,3912,476,108+862,000+17.60%
The Vanguard Group, Inc.2.20%5,222,0732,245,491+2,935,450+128.37%
Geode Capital Management LLC0.54%1,290,365554,857+373,980+40.81%
BlackRock Fund Advisors0.17%403,130173,346+12,052+3.08%
Northern Trust Investments, Inc.0.13%304,248130,827+85,050+38.80%
Hudson Valley Investment Advisors...0.08%200,00086,00000.00%
Acadian Asset Management LLC0.07%167,31871,947+167,318--
Northeast Financial Consultants, ...0.06%150,00064,50000.00%
Benin Management Corp.0.05%123,00052,890+10,000+8.85%
The Bank of New York Mellon Corp....0.05%118,87851,11800.00%

Top 10 Mutual Funds Holding Rexahn Pharmaceuticals Inc

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change